Clinical trial
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
Abstract
This study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS patients
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticlePsilocybin
Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.
ArticleAyahuasca
Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca.
ArticleAyahuasca